Previous studies have revealed that genetic alterations of MAP3K8 were involved in tumorigenic progression in colorectal cancer (Tunca et al., 2013), melanomas (Lehmann et al., 2019; Newman et al., 2019), and lung cancer (Boldrini et al., 2017). Here, MAP3K8 is linked to lung carcinoma.